Asset Management One Co. Ltd. Trims Stock Position in Humana Inc. $HUM

Asset Management One Co. Ltd. lowered its holdings in shares of Humana Inc. (NYSE:HUM) by 1.8% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 55,443 shares of the insurance provider’s stock after selling 1,030 shares during the quarter. Asset Management One Co. Ltd.’s holdings in Humana were worth $13,555,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in HUM. Vanguard Group Inc. increased its holdings in Humana by 8.9% in the 1st quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider’s stock worth $3,697,222,000 after acquiring an additional 1,143,662 shares in the last quarter. AQR Capital Management LLC increased its holdings in Humana by 3,257.5% in the 1st quarter. AQR Capital Management LLC now owns 1,162,600 shares of the insurance provider’s stock worth $307,624,000 after acquiring an additional 1,127,973 shares in the last quarter. Leith Wheeler Investment Counsel Ltd. increased its holdings in Humana by 661.7% in the 2nd quarter. Leith Wheeler Investment Counsel Ltd. now owns 1,038,703 shares of the insurance provider’s stock worth $253,942,000 after acquiring an additional 902,340 shares in the last quarter. Nuveen LLC purchased a new stake in Humana in the 1st quarter worth approximately $171,220,000. Finally, Dodge & Cox increased its holdings in Humana by 5.5% in the 1st quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider’s stock worth $2,845,830,000 after acquiring an additional 557,175 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on HUM. Robert W. Baird reduced their target price on shares of Humana from $300.00 to $297.00 and set a “neutral” rating for the company in a report on Friday, July 25th. Morgan Stanley reduced their target price on shares of Humana from $290.00 to $277.00 and set an “equal weight” rating for the company in a report on Thursday, July 31st. Piper Sandler dropped their price target on Humana from $288.00 to $272.00 and set a “neutral” rating for the company in a research note on Thursday, July 31st. Royal Bank Of Canada upped their price target on Humana from $283.00 to $322.00 and gave the stock an “outperform” rating in a research note on Thursday, August 21st. Finally, Wells Fargo & Company upped their price target on Humana from $344.00 to $347.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Eight analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $297.58.

Humana Stock Down 0.2%

NYSE HUM opened at $290.66 on Monday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. The company has a market capitalization of $34.96 billion, a P/E ratio of 22.31, a P/E/G ratio of 1.70 and a beta of 0.42. Humana Inc. has a one year low of $206.87 and a one year high of $315.35. The stock has a 50 day moving average price of $281.65 and a 200-day moving average price of $258.79.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts’ consensus estimates of $6.32 by ($0.05). The firm had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The firm’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, equities analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a $0.885 dividend. The ex-dividend date is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.2%. Humana’s dividend payout ratio (DPR) is currently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.